Discontinuation report 0.9% SODIUM CHLORIDE INJECTION, USP
| Report ID | 120955 |
| Drug Identification Number | 00060208 |
| Brand name | 0.9% SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | 0.9% Sodium Chloride Injection, USP, 500 mL |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 900MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mL AVIVA Container (JE1323) |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | 2019-05-07 |
| Actual discontinuation date | 2019-05-07 |
| Remaining supply date | 2019-05-07 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-07-23 | French | Compare |
| v1 | 2020-07-23 | English | Compare |
Showing 1 to 2 of 2